PIK3CA and breast cancer: Another study examined the metabolic inhibitors BEZ235, LY294002 and GDC0942 (as PI3K inhibitors) and GDC0980 (a dual PI3K/mTOR inhibitor) and was able to demonstrate the inhibition of breast cancer cell proliferation in high-glucose medium [172].